Company HIGE CAPI

Quantum-SI Incorporated (Quantum-SI), formerly HighCape Capital Acquisition Corp., is focused on semiconductor chip-based proteomics. The Company offers end-to-end, universal single molecule detection solution. The Company's suite of technologies is powered by semiconductor chip designed to enable single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics. Quantum-SI's Time Domain Sequencing technology removes the dependency on color as an identification method, a hurdle for any application outside of genomics where only four colors are needed. The Company has created a single-molecule proteomics and genomics platform with the goal of revolutionizing the growing field of proteomics. The Company's semiconductor chip has the power to decode the molecules of life, starting with proteins, and holds the potential to expand the scale of the genomics and proteomics market.